Detected ·

Elutia

$26MOther

Elutia secured $26M in non-dilutive capital to fully fund the commercial rollout of its NXT-41x antibiotic-eluting biologic for the plastic and reconstructive surgery market.

Amount
$26 000 000 USD
Stage
Other
Event
Funding round
Detected
2026-11-13 04:04:45 UTC
Signal ID
12060748-e758-4499-af35-bb94bf4d92c9

As the API returns it

{
  "id": "12060748-e758-4499-af35-bb94bf4d92c9",
  "created_at": "2026-11-13T04:04:45.763051Z",
  "company_name": "Elutia",
  "company_website_url": "www.elutia.com",
  "company_linkedin_url": "https://www.linkedin.com/company/98670979",
  "event_type": "funding",
  "funding_amount": 26000000,
  "funding_currency": "USD",
  "funding_stage": "other",
  "message": "*Elutia secured $26M in non-dilutive capital to fully fund the commercial rollout of its NXT-41x antibiotic-eluting biologic for the plastic and reconstructive surgery market.*"
}